Getting smart about glucose monitoring
Smartphones may be smart, but sometimes they still are not always accessible.
Enter Smart Meter, a Tampa, Fl.-based company that has recently gained FDA approval for its iGlucose blood glucose meter, which eliminates syncing or paring complications when trying to share blood glucose test results.
“The future is going to be one in which there is more connectivity and more sharing of data than has taken place in the past,” Brahim Zabeli, vice president of sales at Smart Meter, said. Smart Meter gained 510(k) approval in May and is just starting to bring the product to market, he added.
The iGlucose system is a subscription-free glucose meter that is ready out of the box and automatically transmits data to a cloud-based personalized Web portal. The system also allows for real-time communication between the diabetes patient and the patient’s designated caretakers, according to the company.
In addition to enabling connectivity between practitioner and patient, the Smart Meter incorporates an automated virtual care coach and Web-based patient and population management portal into its total offering. “As patients test their blood glucose, they are given feedback that can come to them via SMS, email or both that gives them an ‘attaboy’ for taking the test, or a friendly reminder or a recommendation if their [test result] is out of range,” Zabeli said. “This virtual coaching piece is a pretty critical part of the product offering.”
New OTC hearing aids will call out existing ear care solutions
The Trump Administration in August signed legislation mandating that devices addressing mild-to-moderate hearing loss be made available over the counter, which will create a new in-store destination center for an entire class of products once only available by prescription.
That new destination center also will call out the OTC ear care set, specifically earwax removal solutions, as a natural adjacency. “When you wear a hearing aid [your ear] tends to create more wax,” said Yann Pigeaire, director marketing at Similasan USA. “That’s going to be an area that will continuously grow. The dynamics are favorable to that.” Similasan recently augmented its ear care appeal with its Ear Wax Removal Kit, which includes a one-time use bulb to assist with removal.
In addition to Similasan realizing an ear care opportunity, hearing aid manufacturer Starkey Hearing Technologies launched its Ear Health product line, which includes solutions for earwax, earaches, itchy ears, dry ears and protecting ears from damaging sounds. This move creates a brand resonance for Starkey in the ear care aisle, which may see more hearing aid manufacturers enter the space as hearing aids indicated for mild-to-moderate hearing loss migrate into OTC sets.
“[Starkey] Ear Health products were designed to give consumers an easy way to take care of their ears,” said Chris McCormick, chief marketing officer at Starkey. “It is our hope that because of these products, we will see more people take an earlier and more proactive approach to ear and hearing health, which will in turn lead to overall improved health and wellness.”
Foundation Consumer Healthcare closes Plan B One-Step buy, names new CEO
PITTSBURGH — Foundation Consumer Healthcare has announced a new addition to its product offerings. The company has completed its $675 million acquisition of Plan B One-Step and two value emergency contraceptive brands from Teva. Alongside its new products, the company has added Greg Bradley, a 34-year CPG industry veteran, as its president and CEO.
“As the #1 OB/GYN recommended OTC emergency contraceptive brand and an important birth control option for women across the United States, Plan B One-Step is the perfect addition to our growing portfolio,” Bradley said. “We look forward to devoting immense resources to support Plan B One-Step and working closely with our retail partners to ensure continued access to this critical women’s health product.”
Bradley’s experience includes improving in-market performance of existing OTC healthcare brands. He has worked at GlaxoSmithKline overseeing several prescription-to-OTC switches, and founded Advantage Consumer Healthcare in 2011. Advantage Consumer Healthcare specialized in OTC switches and healthcare product launches. Foundation Consumer Healthcare said Advantage Consumer Healthcare would remain as its OTC selling partners.
Among the products marketed by Foundation Consumer Healthcare is St. Joseph Aspirin, Theravent, Neo-Synephrine, Bronkaid and Campho Phenique. The company’s senior leadership has more than 80 years of collective experience, it said.
“The senior leadership team at FCH is dedicated to supporting innovative therapies and focused on driving growth across our product portfolio,” Bradley said. “As the category leader, Plan B One-Step plays an important role in women’s health, and FCH is eager to invest the resources and thinking necessary to help Plan B One-Step fulfill that role.”